Radiotherapy of brain metastases from non-small cell lung cancer
Journal of Cancer Metastasis and Treatment, cilt.5, 2019 (Scopus)
- Yayın Türü: Makale / Derleme
- Cilt numarası: 5
- Basım Tarihi: 2019
- Doi Numarası: 10.20517/2394-4722.2018.73
- Dergi Adı: Journal of Cancer Metastasis and Treatment
- Derginin Tarandığı İndeksler: Scopus
- Anahtar Kelimeler: brain metastases, lung cancer, Radiotherapy, stereotactic radiosurgery, stereotactic radiotherapy, whole-brain radiotherapy
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Brain metastases risk at the time of diagnosis or during the course of disease is high in non-small cell lung cancer (NSCLC). Even the incidence of brain metastases has increased in recent years, due to detection of smaller asymptomatic lesions with MRI screening as well as improved survival as a consequence of developments in systemic therapies. In the last decade, there have been many trials in the management of NSCLC patients with brain metastases, questioning the role of adjuvant whole brain radiotherapy (WBRT) after surgery or stereotactic radiosurgery (SRS), WBRT, compared to best supportive care in patients not amenable to surgery, aggressive local therapies in solitary brain metastases, postsurgical cavity SRS, SRS in non-oligometastatic patients, cranial radiotherapy in patients with driver mutations, thyrosine kinase inhibitors, immune check point inhibitors and the impact of therapies on neurocognitive functions and quality of life. The main objective of this review is to provide an update on current trends in radiotherapy in the management of newly diagnosed brain metastases from NSCLC.